Molecular mechanism of AMPA receptor noncompetitive antagonism
- PMID: 16242408
- DOI: 10.1016/j.neuron.2005.09.024
Molecular mechanism of AMPA receptor noncompetitive antagonism
Abstract
AMPA-type glutamate receptors are specifically inhibited by the noncompetitive antagonists GYKI-53655 and CP-465,022, which act through sites and mechanisms that are not understood. Using receptor mutagenesis, we found that these antagonists bind at the interface between the S1 and S2 glutamate binding core and channel transmembrane domains, specifically interacting with S1-M1 and S2-M4 linkers, thereby disrupting the transduction of agonist binding into channel opening. We also found that the antagonists' affinity is higher for agonist-unbound receptors than for activated nondesensitized receptors, further depending on the level of S1 and S2 domain closure. These results provide evidence for substantial conformational changes in the S1-M1 and S2-M4 linkers following agonist binding and channel opening, offering a conceptual frame to account for noncompetitive antagonism of AMPA receptors.
Similar articles
-
Stargazin modulates AMPA receptor antagonism.Neuropharmacology. 2008 Jun;54(7):1062-70. doi: 10.1016/j.neuropharm.2008.02.012. Epub 2008 Mar 4. Neuropharmacology. 2008. PMID: 18378265
-
Structural Bases of Noncompetitive Inhibition of AMPA-Subtype Ionotropic Glutamate Receptors by Antiepileptic Drugs.Neuron. 2016 Sep 21;91(6):1305-1315. doi: 10.1016/j.neuron.2016.08.012. Epub 2016 Sep 8. Neuron. 2016. PMID: 27618672 Free PMC article.
-
Glutamate receptor trafficking: endoplasmic reticulum quality control involves ligand binding and receptor function.J Neurosci. 2005 Mar 2;25(9):2215-25. doi: 10.1523/JNEUROSCI.4573-04.2005. J Neurosci. 2005. PMID: 15745947 Free PMC article.
-
Synthesis and structure-activity relationships of 2,3-benzodiazepines as AMPA receptor antagonists.Mini Rev Med Chem. 2001 Sep;1(3):243-53. doi: 10.2174/1389557013406783. Mini Rev Med Chem. 2001. PMID: 12369971 Review.
-
2,3-benzodiazepine-type AMPA receptor antagonists and their neuroprotective effects.Neurochem Int. 2008 Jan;52(1-2):166-83. doi: 10.1016/j.neuint.2007.07.002. Epub 2007 Jul 10. Neurochem Int. 2008. PMID: 17707550 Review.
Cited by
-
Structure and gating of tetrameric glutamate receptors.J Physiol. 2015 Jan 1;593(1):29-38. doi: 10.1113/jphysiol.2013.264911. Epub 2013 Nov 25. J Physiol. 2015. PMID: 25556785 Free PMC article. Review.
-
A novel family of negative and positive allosteric modulators of NMDA receptors.J Pharmacol Exp Ther. 2010 Dec;335(3):614-21. doi: 10.1124/jpet.110.174144. Epub 2010 Sep 21. J Pharmacol Exp Ther. 2010. PMID: 20858708 Free PMC article.
-
Glutamate receptor ion channels: structure, regulation, and function.Pharmacol Rev. 2010 Sep;62(3):405-96. doi: 10.1124/pr.109.002451. Pharmacol Rev. 2010. PMID: 20716669 Free PMC article. Review.
-
Role of the Ion Channel Extracellular Collar in AMPA Receptor Gating.Sci Rep. 2017 Apr 21;7(1):1050. doi: 10.1038/s41598-017-01146-z. Sci Rep. 2017. PMID: 28432359 Free PMC article.
-
Synthesis and molecular docking of novel non-competitive antagonists of GluK2 receptor.Med Chem Res. 2015;24(2):810-817. doi: 10.1007/s00044-014-1171-1. Epub 2014 Jul 24. Med Chem Res. 2015. PMID: 25620864 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous